Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Alnylam Pharmace. buy AlexM84

Alnylam Pharmace.
Start price
€134.80
17.03.24 / 50%
Target price
-
17.04.24
Performance (%)
0.48%
End price
€135.45
18.04.24
Summary
This prediction ended on 18.04.24 with a price of €135.45. The BUY prediction by AlexM84 for Alnylam Pharmace. closed nearly unchanged. AlexM84 has 50% into this prediction

Alnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.

AI-generated
Performance without dividends (%)
Name 1w 1m 1y
Alnylam Pharmace. 2.484% 2.484% -49.814%
iShares Core DAX® -1,28 % 4,21 % 7,08 %
iShares Nasdaq 100 -3,34 % -1,74 % 26,18 %
iShares Nikkei 225® -4,29 % -1,62 % 44,32 %
iShares S&P 500 -2,31 % -0,10 % 20,82 %

Comments by AlexM84 for this prediction

In the thread Trading Alnylam Pharmace.
Prediction Buy
Perf. (%) 0.48%
Target price
Change
Ends at 17.04.24

Die von AlexM84 gewählte maximale Laufzeit wurde überschritten

AlexM84 
0
Report Share
18.04.24